Literature DB >> 15617831

Down-regulation of DNA polymerases kappa, eta, iota, and zeta in human lung, stomach, and colorectal cancers.

Qiangrong Pan1, Yongming Fang, Yang Xu, Kun Zhang, Xun Hu.   

Abstract

Human DNA polymerases kappa, eta, iota, and zeta are responsible for the translesion DNA synthesis. Numerous in vitro studies indicated that these enzymes may contribute to DNA lesion-triggered and spontaneous mutation. We measured the transcripts of these 4 enzymes in 131 self-paired cancerous and non-tumor samples, including 23 lung cancers, 49 stomach cancers, and 59 colorectal cancers. Our results indicated that, except pol eta in colorectal cancers, these enzymes are all significantly down-regulated in human lung, stomach, and colorectal cancers, suggesting that these enzymes are probably not closely associated with the elevated mutations in human cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15617831     DOI: 10.1016/j.canlet.2004.07.021

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  25 in total

1.  DNA polymerase theta up-regulation is associated with poor survival in breast cancer, perturbs DNA replication, and promotes genetic instability.

Authors:  Fanny Lemée; Valérie Bergoglio; Anne Fernandez-Vidal; Alice Machado-Silva; Marie-Jeanne Pillaire; Anne Bieth; Catherine Gentil; Lee Baker; Anne-Laure Martin; Claire Leduc; Elena Lam; Eddy Magdeleine; Thomas Filleron; Naïma Oumouhou; Bernd Kaina; Mineaki Seki; Fanny Grimal; Magali Lacroix-Triki; Alastair Thompson; Henri Roché; Jean-Christophe Bourdon; Richard D Wood; Jean-Sébastien Hoffmann; Christophe Cazaux
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-12       Impact factor: 11.205

2.  Aberrant Kynurenine Signaling Modulates DNA Replication Stress Factors and Promotes Genomic Instability in Gliomas.

Authors:  April C L Bostian; Robert L Eoff
Journal:  Chem Res Toxicol       Date:  2016-08-15       Impact factor: 3.739

Review 3.  Translesion DNA Synthesis in Cancer: Molecular Mechanisms and Therapeutic Opportunities.

Authors:  Maroof K Zafar; Robert L Eoff
Journal:  Chem Res Toxicol       Date:  2017-09-28       Impact factor: 3.739

4.  DNA damage tolerance: a double-edged sword guarding the genome.

Authors:  Gargi Ghosal; Junjie Chen
Journal:  Transl Cancer Res       Date:  2013       Impact factor: 1.241

Review 5.  POLE proofreading defects: Contributions to mutagenesis and cancer.

Authors:  Vivian S Park; Zachary F Pursell
Journal:  DNA Repair (Amst)       Date:  2019-02-16

Review 6.  DNA polymerases and cancer.

Authors:  Sabine S Lange; Kei-ichi Takata; Richard D Wood
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

7.  Elevated DNA polymerase iota (Poli) is involved in the acquisition of aggressive phenotypes of human esophageal squamous cell cancer.

Authors:  Haoyao Sun; Shitao Zou; Shuyu Zhang; Biao Liu; Xingjun Meng; Xiaoqing Li; Jian Yu; Jinchang Wu; Jundong Zhou
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

8.  REV3L confers chemoresistance to cisplatin in human gliomas: the potential of its RNAi for synergistic therapy.

Authors:  Huibo Wang; Shu-Yu Zhang; Shuai Wang; Juan Lu; Wenting Wu; Lin Weng; Dan Chen; Yu Zhang; Zhipeng Lu; Jingmin Yang; Yuanyuan Chen; Xu Zhang; Xiaofeng Chen; Caihua Xi; Daru Lu; Shiguang Zhao
Journal:  Neuro Oncol       Date:  2009-12       Impact factor: 12.300

9.  Mechanism of replicative DNA polymerase delta pausing and a potential role for DNA polymerase kappa in common fragile site replication.

Authors:  Erin Walsh; Xiaoxiao Wang; Marietta Y Lee; Kristin A Eckert
Journal:  J Mol Biol       Date:  2012-11-19       Impact factor: 5.469

10.  Implications of genetic heterogeneity in cancer.

Authors:  Michael W Schmitt; Marc J Prindle; Lawrence A Loeb
Journal:  Ann N Y Acad Sci       Date:  2012-09       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.